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ABSTRACT 
 
 
Background:  Mechanical thrombectomy is the gold standard for treating patients with certain 
acute ischemic stroke (AIS) due to large vessel occlusion (LVO). However, even with major 
advancements and increasing procedural volumes, acute endovascular therapy remains a high-
risk procedure with a considerable 90-day mortality rate, affected by a variety of factors.  
 
Purpose:  To investigate various clinical and procedural factors associated with 90-day mortality 
in patients undergoing mechanical thrombectomy for emergent treatment of AIS and determine 
which of these factors made unique contributions to post-thrombectomy prognosis. 
 
Methods:  We examined a prospective registry of 323 patients treated with endovascular 
thrombectomy for AIS between 2016 and 2019 at a high-volume comprehensive stroke center in 
central Massachusetts. We developed two multivariable logistic regression models adjusting for 
the contributions of baseline characteristics and recanalization parameters, to identify potential 
predictors of mortality at 90 days.  
 
Results:  Among 323 AIS patients treated with mechanical thrombectomy, the overall rate of 
successful recanalization was 86% and the overall post-procedure mortality rate was 29% by 90 
days. After univariate analysis, a baseline multivariable model comprised of: history of stroke 
(OR 0.28, 95% CI 0.09 – 0.68), pre-stroke modified Rankin Scale (mRS 2: OR 3.75, 95% CI), 
severe admission National Institutes of Health Stroke Scale (NIHSS 21–42: OR 12.36, 95% CI 
1.48 – 103.27), internal carotid artery (ICA) occlusion (OR 2.77, 95% CI 1.18 – 6.55), and 
posterior circulation occlusion (OR 2.69, 95% CI 1.06 – 6.83) was prognostic of 90-day 
mortality. A second multivariable model also found the procedural factors of: clot obtained after 
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each pass (OR 0.49, 95% CI 0.24 – 1.00), successful recanalization (OR 0.21, 95% CI 0.06 – 
0.8) and symptomatic intracranial hemorrhage (sICH; OR 17.89, 95% CI 5.22 – 61.29) to be 
identifiable predictors of post-thrombectomy mortality. 
 
Conclusion: Death within 90 days after thrombectomy was increased among patients with higher 
pre-stroke disability, higher stroke severity on admission, ICA or posterior occlusion, and those 
with sICH complication. A history of stroke, clot extraction after each device pass, and 
successful recanalization are associated with decreased 90-day mortality. These identifiable 
contributors may inform patient selection, prognosis evolution, and shared decision-making 
regarding emergent thrombectomy for treatment of AIS. 
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CHAPTER I: INTRODUCTION  
 
 
Background 
Despite significant advances in stroke treatment and risk reduction over the past decade, 
stroke remains the second leading cause of death worldwide and the top source of permanent 
disability in the United States.1 The majority (87%) of strokes are ischemic in nature,2 and 
between one quarter and one-half of these strokes are due to large vessel occlusions (LVOs).3-5 
These blockages endanger large cerebrovascular territories, are often refractory to intravenous 
tissue-plasminogen activator (IV t-PA), and are associated with high rates of morbidity and 
mortality without endovascular intervention.  
Several randomized controlled trials (RCTs) have recently demonstrated the effectiveness 
of new mechanical thrombectomy devices over IV t-PA, bringing about the “endovascular era” 
of acute ischemic stroke (AIS) treatment.6-10 Mechanical thrombectomy is now considered the 
gold standard in treating patients with certain anterior (proximal middle cerebral artery and 
internal carotid artery) occlusions who present within 6 hours of stroke onset.6,13 Following 
evidence from recent RCTs, 2018 national guidelines have extended the recommended operable 
window to include certain LVO strokes presenting within 24 hours of stroke onset.11-13 
Guidelines have also expanded indications for thrombectomy to include distal cerebral segments 
and posterior circulation occlusions.  
Even with rapidly increasing procedural volumes and overall improved clinical 
outcomes, emergent thrombectomy remains a challenging and high-risk procedure with a 
considerable (up to 39%) mortality rate.15-17 In multi-center registries, approximately 1 in 5 
stroke patients who undergo mechanical thrombectomy die within 90 days of the procedure, and 
many who survive are left with severe disability. 6-7,14 Furthermore, most stroke patients who 
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undergo mechanical thrombectomy in clinical practice would not have qualified for 
randomization in the carefully selected arms of the endovascular RCTs, thereby limiting 
generalizability to many real-world patients with LVO strokes.18  
Objectives 
Not only is there uncertainty regarding the risks and benefits of endovascular therapy in a 
more generalizable patient population, the factors affecting death after successful thrombectomy 
are variable. As the indications for mechanical thrombectomy continue to expand, the ability to 
predict the occurrence of adverse clinical outcomes after endovascular intervention will be 
important for patient selection, clinical management, and the duration of follow-up. The purpose 
of this single-center observational study was to examine various clinical and procedural factors 
associated with 90-day mortality in patients undergoing mechanical thrombectomy for emergent 
treatment of AIS at a high-volume comprehensive stroke center in central New England. 
Findings may help clinicians evaluate post-thrombectomy prognosis and identify areas to 
improve upon thrombectomy-related mortality and complication rates, in the hopes of providing 
meaningful data to frame shared clinical decision making between physicians, patients, and their 
families. 
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CHAPTER II: STUDY METHODOLOGY  
 
 
Patient Selection  
The Department of Neuro-Interventional Radiology at the University of Massachusetts 
Medical School (UMMS) maintained a prospective registry of all patients at this institution who 
were treated with endovascular therapy beginning in 2016. A retrospective analysis was 
performed on all patients with AIS in the registry who underwent mechanical thrombectomy at 
this large comprehensive stroke center from June 2016 to August 2019. This single-center 
observational study was approved by the UMMS Institutional Review Board.  
Patients who met the following criteria were included: 1)  aged 18 years or older; 2) 
presented with AIS and LVO of the anterior or posterior circulation; 3) had confirmatory 
imaging of the target vessel using computed tomography (CT), magnetic resonance imaging 
(MRI), or angiography; 4) underwent mechanical thrombectomy within 24 hours of stroke 
symptom onset (i.e., patient’s last known well) using stent retrievers or large-bore distal 
aspiration catheters; and 5) received stent implantation, balloon angioplasty, or intra-arterial 
rescue therapy in the event of recanalization failure. Patients who had intracranial hemorrhage 
(ICH) prior to intervention or patients in whom no thrombectomy was attempted due to 
spontaneous recanalization or IV thrombolysis were excluded. A total of 323 patients met our 
study inclusion criteria during the period under study.  
Baseline Variables and Clinical Assessment 
Patients’ demographic information, clinical characteristics, and imaging results were 
prospectively collected from the time of hospital admission to discharge and the 3-month follow-
up. Comorbid conditions and 90-day mortality status were extracted from the electronic medical 
record and confirmed with matching records in the UMMS Data Lake repository.19 Candidate 
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risk factors known or hypothesized to be pertinent to stroke morbidity and mortality were 
abstracted from patient chart review as well, including history of prior stroke or transient 
ischemic attack (TIA), hypertension, diabetes, hyperlipidemia, coronary artery disease, atrial 
fibrillation, active smoking, and alcohol use.14-17 The modified Rankin Scale (mRS) and National 
Institutes of Health Stroke Scale (NIHSS) were scored upon patients’ initial stroke presentation. 
The mRS is a standard measure of global disability and was used to assess pre-stroke functional 
status.20 This integer scale ranges from 0 (no symptoms and total functional independence) to 5 
(severe disability requiring nursing care) and 6 (death).10 The 0 to 42 point NIHSS involved a 
neurologic exam upon admission that quantified neurologic deficit in the setting of acute stroke. 
NIHSS was categorized into levels of stroke severity: minor (0-4), moderate (5-15), moderate-to-
severe (16-20), and severe (21-42) according to standard classification.21 The sites of anterior 
vessel occlusion were divided into the middle cerebral artery (MCA), internal carotid artery 
(ICA), and ICA-MCA tandem occlusion; sites of posterior circulation occlusion were partitioned 
into the basilar or posterior cerebral artery (PCA) as confirmed on brain imaging. 
Endovascular Procedure 
 Endovascular therapy was performed under general anesthesia or conscious sedation in 
the neuro-angiography suite. Mechanical thrombectomy with the newest generation stent 
retriever system (Trevo or Solitaire) was the first-line approach for achieving recanalization 
irrespective of IV t-PA use. If multiple passes of the retriever device failed to remove the 
thrombus, manual aspiration thrombectomy with a reperfusion catheter (Penumbra) was 
performed. In cases of severe intracranial atherosclerosis or vessel dissection, intracranial 
balloon angioplasty was performed with or without stenting to preserve restored patency of the 
occluded segment. Intra-arterial thrombolytics were rarely used to treat distal emboli not 
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accessible to the device. All treated vessels were examined for significant vasospasm on follow-
up angiography after retraction of the stent retriever and treated with intra-arterial verapamil if ≥ 
50% luminal stenosis was found.22 Further details of these mechanical thrombectomy techniques 
have been previously described.22-23  
Procedural Measures and Outcome Assessment  
The time from stroke onset to percutaneous groin puncture was recorded at the start of 
the procedure, marking both the time window of brain ischemia and when thrombectomy was 
initiated. The time to vessel recanalization (in minutes) was calculated from groin arterial access 
(time zero) to when blood flow to the target vessel was effectively restored (or time stamp on 
final CT angiogram if revascularization was not achieved). Other intraprocedural measures 
assessed included the number of passes attempted with the thrombectomy device and whether or 
not a clot was obtained after each pass. 
The degree of arterial occlusion was assessed after each pass of the device and on the 
final angiogram according to the modified thrombolysis in cerebral infarction (mTICI) score 
classification.24-26 No or incomplete vessel filling was considered recanalization failure, 
receiving a mTICI grade of 0, 1, or 2A. Successful revascularization status was defined as a 
mTICI score of 2B (greater than 50% antegrade reperfusion of the occluded artery and its 
ischemic territory) to 3 (complete reperfusion with normal distal branch filling).25  
Patients were evaluated for periprocedural complications and adverse events in real time. 
Serial CT angiography was conducted to detect expansion or resolution of the infarct territory, 
distal thrombus embolization, and vessel perforation or dissection. All patients underwent a 
routine post-procedure CT within 12 to 36 hours of thrombectomy to evaluate the presence of 
intracranial hemorrhage. Symptomatic intracranial hemorrhage (sICH) was defined as a 
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subarachnoid or intraparenchymal hemorrhage associated with ≥ 4 point worsening of NIHSS or 
≥ 1 point deterioration in level of consciousness. The primary study outcome measure was 
patient mortality occurring within 90 days following AIS presentation, with death defined as a 
mRS of 6 and confirmed by patient death date recorded in the EMR. 
Statistical Analysis 
 We examined the association between a number of demographic and clinical prognostic 
variables with 3 month death rates, comparing patients who survived and died. Statistical 
analyses were performed using SAS version 9.4 (SAS Institute Inc., Cary NC) or StataIC 
Statistical Software, release 16 (StataCorp LP, College Station, TX). Categorical variables were 
presented as counts (n) and percentages (%) and compared between patients who had survived or 
died during the 3 month follow-up period using the chi-square test. Continuous variables were 
presented as means and standard deviations (SD) or medians and interquartile ranges (IQR) as 
appropriate, then compared using the independent two-sample t-test. Normality of distributions 
was assessed using histograms. Candidate factors from Tables 1 and 2 which were hypothesized 
or previously identified (from literature review and discussion with a neurointerventionalist) as 
affecting patients’ mortality status were entered into univariable logistic regression as covariates 
(Table 3).  
Baseline demographic, clinical, and procedural variables that were clinically relevant and 
reached a significance threshold of p ≤ 0.15 in univariate analyses were considered for 
subsequent entry into two multivariable logistic regression models. The first multivariable model 
(Model 1, Table 4) analyzed independent baseline characteristics and was developed using 
backward selection, with a significance level of p ≤ 0.05 for variable retention. The second pre-
specified model (Model 2, Table 4) added procedural characteristics to the baseline prognostic 
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factors identified in Model 1, to examine the combined effect of both baseline and interim 
thrombectomy variables on 90-day mortality status. Model 2 selected procedural variables 
meeting p ≤ 0.05 significance criteria and allowed for retention of baseline prognosticators not 
meeting this threshold if they were of particular clinical relevance and consistent with prior 
literature.11, 14-17 Model fit was assessed and compared using Akaike’s information criterion 
(AIC).  
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CHAPTER III: STUDY RESULTS  
 
 
Patient Characteristics 
 Baseline demographic and clinical characteristics of the study population are shown in 
Table 1. The average age of the study population was 71.5 ± 15.5 years, 50.2% were women, and 
82% were of Caucasian race. Among the 323 patients treated with mechanical thrombectomy for 
AIS, 92 (28.5%) died during the 90 day post-procedural period. Overall, those who died within 
90 days post-thrombectomy were significantly older, by an average of 6 years compared with 
those who survived this high risk period (Table 1). Patients who survived thrombectomy 
treatment for their LVO stroke were significantly more likely to have had a prior stroke or TIA 
than those who died. Alcohol use (defined in the medical record as any amount of consumption) 
was significantly higher in those who survived compared with those who died (Table 1). The 
rates of other common comorbid medical conditions including hypertension, diabetes, 
hyperlipidemia, coronary artery disease, and atrial fibrillation were not significantly different 
between those who survived versus those who died during the 3 month follow-up period.  
Patients who died within 90 days had significantly higher pre-stroke mRS disability 
(mean score 1.4 points vs. 0.7 points,) as well as significantly higher admission NIHSS stroke 
severity (mean score 20.1 vs. 15.2 points) than those who died (Table 1). A large majority of the 
treated acute anterior circulation strokes were MCA strokes (220, 77.5%); 35 were ICA strokes 
and 29 were MCA-ICA occlusions. Of the treated posterior circulation strokes, 23 were due to 
basilar artery occlusion and 4 were due to PCA occlusions. The proportion of ICA occlusions 
was nearly double in those who died than in those who were alive 90 days after thrombectomy 
(16.3% vs. 8.7%,). There was also a higher proportion of posterior circulation strokes in patients 
who died compared to patients who survived (Table 1).  
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Procedural Characteristics 
Among the 323 patients with a confirmed LVO, less than half (39%) received IV tPA 
prior to their endovascular procedure. Most patients (86%) who underwent thrombectomy were 
treated under general anesthesia. Patients who died within 90 days after thrombectomy had an 
approximate 50 minute longer median stroke onset to groin puncture time compared to patients 
who survived. It also took longer to recanalize patients who ended up dying within 90 days of the 
procedure (Table 2).  
 The need for additional passes (explored as a continuous variable) of the stent-retriever 
device to extract the thrombus was associated with a significant increase in the 3 month death 
rate, especially if 3 or more device passes were used. Survivors of thrombectomy were 
significantly more likely to have had a clot obtained after each device pass (64.1%) than non-
survivors (48.9%). Successful recanalization to a mTICI score of 2B or 3 (majority to complete 
vessel reperfusion) was achieved in 87% of surviving patients and 84% of deceased patients.  
Among the patients in whom first-line stent-retriever thrombectomy was attempted, 44 
experienced initial recanalization failure requiring rescue angioplasty in the form of balloon 
dilation or stent implantation and 25 required intra-arterial thrombolytic (t-PA) or anti-platelet 
therapy (eptifibatide). The need for rescue or intra-arterial therapy during the procedure was not 
associated with mortality in exploratory or subsequent regression analyses. The 3 month post-
procedure survivors experienced significantly fewer intraprocedural complications as well as 
significantly fewer ICH overall and fewer symptomatic ICH 12 to 36 hours post-thrombectomy 
compared with those who died during this period (Table 2).  
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Univariate Analysis 
 In terms of baseline characteristics, advanced age, a history of prior stroke or TIA, 
current alcohol use, higher pre-stroke mRS, admission NIHSS, and occlusion site in the ICA 
were associated with dying within 90 days of thrombectomy intervention for AIS (Table 1). 
Procedural parameters including the number of device passes, extraction of a clot after each pass, 
successful recanalization, and intraprocedural complications in the form of ICH or sICH also 
reached statistical significance in distinguishing survivors from non-survivors of thrombectomy 
after stroke (Table 2). Variables such as a history of coronary artery disease, posterior circulation 
occlusion, the time it took to recanalize the vessel, the need for rescue angioplasty or intra-
arterial therapy, and the dislodging of distal emboli during the procedure either approached 
statistical significance or were considered to be clinically relevant. These variables were also  
included in our univariable logistic regression analyses (Table 3).  
Multivariable Models  
Two parsimonious models were developed from our multivariable adjusted regression 
analyses and summarized in Table 4. Categorizing continuous variables (mRS and NIHSS) did 
not appreciably modify the magnitude of effects found in either model. The first model was built 
from backward selection of relevant baseline factors only. Model 1 revealed that greater pre-
stroke functional disability (mRS 2: OR 3.75, 95% CI 1.50 – 9.39; mRS 3: OR 3.39, 95% CI 1.55 
– 7.42; mRS 4: OR 6.25, 95% CI 1.72 – 22.66), severe stroke deficit on admission (NIHSS 21–
42: OR 12.36, 95% CI 1.48 – 103.27), ICA occlusion (OR 2.77, 95% CI 1.18 – 6.55), and 
posterior circulation occlusion (OR 2.69, 95% CI 1.06 – 6.83) were associated with post-
thrombectomy mortality at 90 days. History of stroke or TIA (OR 0.28, 95% CI 0.09 – 0.68) was 
inversely associated with mortality at 90 days.  
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Model 2 combined the influential baseline factors identified in Model 1 with pre-
specified procedural characteristics. Clot obtained after each pass (OR 0.49, 95% CI 0.24 – 1.00) 
and successful recanalization to ≥ 2B (OR 0.21, 95% CI 0.06 – 0.8) were inversely correlated 
with death at 90 days, while sICH 12 to 36 hours post-procedure (OR 17.89, 95% CI 5.22 – 
61.29) was independently associated with mortality after thrombectomy for AIS. The effects of 
baseline prognostic factors from Model 1 were not substantially changed when procedural 
parameters were incorporated into Model 2. Pre-stroke functional disability (mRS 2: OR 4.43, 
95% CI 1.55 – 12.65; mRS 3: OR 3.84, 95% CI 1.56 – 9.45; mRS 4: OR 5.06, 95% CI 1.09 – 
23.51), severe stroke deficit on admission (NIHSS 21–42: OR 56.36, 95% CI 1.28 – 999.99, and 
ICA occlusion (OR 3.28, 95% CI 1.22 – 8.86) retained their statistical significance after 
multivariable adjustment. Having a history of stroke or TIA (OR 0.27, 95% CI 0.07 – 1.05) or a 
posterior site of occlusion (OR 1.95, 95% CI 0.65 – 5.83) did not appear to statistically influence 
the risk of death after thrombectomy in Model 2 after adding procedural variables and holding 
other baseline variables constant. However, these factors were retained in the second model 
given their clinical relevance and demonstrated importance with endovascular outcomes.11, 17, 31, 
32 The AIC was lower in Model 2 (AIC = 263.4) compared to Model 1 (AIC = 323.3), thus the 
consideration of procedural variables with baseline characteristics may result in a better fitting 
and more predictive multivariable model for assessing the risk of dying at 3 months among 
patients with an AIS undergoing thrombectomy. 
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Table 1.  Baseline Characteristics of Patients According to Survival Status  
at 90 Days Post-Thrombectomy 
Characteristic Alive  (n=231)  
Died 
(n=92)  
P–Value 
Demographic — no. (%)  
Age — mean ± SD: 69.8 ± 15.7 75.8 ± 14.1 0.002* 
< 60 years 47 (20.3) 9 (9.8) 0.005* 
60 – 69 years 42 (18.2) 28 (30.4) 0.021* 
70 – 79 years 76 (32.9) 43 (46.7) 0.019* 
≥ 80 years 63 (27.3) 12 (13.0) 0.025* 
Sex:                                      Male 120 (51.9) 41 (44.6) 0.22 
Race:                            Caucasian 187 (81.0) 78 (84.8) 0.42 
Medical history — no. (%):  
Prior stroke or TIA  35 (15.2) 5 (5.4) 0.017* 
Hypertension  134 (58.0) 55 (59.8) 0.83 
Diabetes mellitus 50 (21.6) 21 (22.8) 0.85 
Hyperlipidemia 82 (35.5) 31 (33.7) 0.76 
Coronary artery disease 36 (15.6) 22 (23.9) 0.08 
Atrial fibrillation  75 (32.5) 31 (33.7) 0.83 
Active smoking  70 (30.3) 30 (32.6) 0.69 
Alcohol use 63 (27.3) 14 (15.2) 0.022* 
Clinical parameters — no. (%)  
Pre-stroke mRS — mean ± SD: 0.7 ± 1.2 1.4 ± 1.4 <0.001* 
No symptoms – mRS 0 144 (62.3) 37 (40.2) <0.001* 
No disability – mRS 1 29 (12.6) 13 (14.1) 0.76 
Slight disability – mRS 2 15 (6.5) 14 (15.2) 0.016* 
 Moderate disability – mRS 3 23 (10.0) 19 (20.7) 0.013* 
Moderately severe – mRS 4 7 (3.0) 6 (6.5) 0.16 
Admission NIHSS — mean ± SD: 15.2 ± 7.4 20.1 ± 8.4 <0.001* 
Minor (NIHSS 0 – 4) 14 (6.1) 2 (2.2) 0.14 
Moderate (NIHSS 5 – 15) 98 (42.4) 19 (20.7) <0.001* 
Moderate–Severe (NIHSS 16 – 20) 57 (24.7) 24 (26.1) 0.83 
Severe (NIHSS 21 – 42) 52 (22.5) 44 (47.8) <0.001* 
Site of occlusion — no. (%):  
Middle cerebral artery 162 (70.1) 58 (63) 0.22 
Internal carotid artery 20 (8.7) 15 (16.3) 0.046* 
Tandem MCA–ICA  23 (10.0) 6 (6.5) 0.33 
Posterior circulation: 16 (6.9) 11 (12.0) 0.14 
Basilar artery 14 (6.1) 9 (9.8) 0.24 
Posterior cerebral artery 2 (0.9) 2 (2.2) 0.34 
 
-Values are N (% of Alive or Died), unless otherwise specified as mean ± standard deviation (SD).  
-Categorical variables were compared using chi-square test. Continuous variables were compared using student’s T-test. 
*Statistically significant. The alpha level for significance for pairwise comparisons was 0.05. 
-TIA, transient ischemic attack; mRS, modified Rankin Scale; NIHSS, National Institute of Health Stroke Scale; MCA, 
middle cerebral artery; ICA, internal carotid artery; PCA, posterior cerebral artery. 
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Table 2.  Procedural Characteristics of Patients According to Survival Status 
at 90 Days Post-Thrombectomy 
 Characteristic Alive  (n=231)  
Died 
(n=92)  
P–Value 
Pre-treatment characteristics — no. (%)  
Intravenous t-PA 89 (38.5) 37 (40.2) 0.88 
General anesthesia  198 (85.7) 81 (88.0) 0.42 
Stroke onset to groin puncture (min)ǁ 270 (180.5 – 544) 320 (159 – 564) 0.44 
Endovascular measures — no. (%)  
Number of device passes:¶ 1.9 ± 1.1 2.3 ± 1.6 0.010* 
1 pass 101 (43.7) 35 (38.0) 0.18 
2 passes 57 (24.7) 21 (22.8) 0.54 
≥ 3 passes 60 (26.0) 36 (39.1) 0.044* 
Clot obtained after each pass  148 (64.1) 45 (48.9) 0.001* 
Successful recanalization (≥ 2B) 201 (87.0) 77 (83.7) <0.001* 
Time to recanalization (min)ǁ 50 (31 – 83) 56.5 (36.5 – 83.5) 0.15 
Rescue angioplasty† 30 (13.0) 14 (15.2) 0.60 
Intra-arterial therapy‡ 20 (8.7) 5 (5.4) 0.33 
Periprocedural adverse events — no. (%)  
Any procedural complication: 59 (25.5) 44 (47.8) <0.001* 
Distal embolization 21 (9.1) 9 (9.8) 0.85 
Any intracranial hemorrhage 40 (17.3) 33 (35.9) <0.001* 
Symptomatic ICH§ 4 (1.7) 27 (29.3) <0.001* 
 
Values are N (% of Alive or Died), unless otherwise specified as: ¶mean ± standard deviation (SD) or ǁmedian interquartile range 
(IQR). Categorical variables were compared using chi-square test. Continuous variables were compared using student’s T-test. 
*Statistically significant. The alpha level for significance for pairwise comparisons was 0.05. 
-IV t-PA, intravenous tissue-plasminogen activator; mTICI denotes modified Treatment in Cerebral Ischemia classification, with 
scores ranging from 0 (no flow) to 3 (normal flow). Recanalization was defined as a TICI score of 2B or 3 (≥50% or complete 
restoration of flow at the site of arterial occlusion.) 
†Techniques included balloon dilation and stent implantation. 
‡Intra-arterial thrombolytics (t-PA) or anti-platelet therapy (eptifibatide) 
  
§Symptomatic intracerebral hemorrhage (ICH) was defined as subarachnoid or intraparenchymal hemorrhage at 12–36 hours 
associated with ≥ 4 point worsening of NIHSS or ≥ 1 point deterioration in level of consciousness.  
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Table 3.  Univariate Logistic Regression of Characteristics Associated 
with 90–Day Mortality 
Variable OR 95% CI 
Baseline Characteristics 
Age: 
60 – 69 years* 1.01 0.39 – 2.58 
70 – 79 years* 3.50 1.60 – 7.64 
≥ 80 years* 2.97 1.44 – 6.11 
Medical history:   
Prior stroke or TIA 0.32 0.12 – 0.85 
Coronary artery disease 1.70 0.94 – 3.09 
Alcohol use 0.48 0.25 – 0.91 
Pre-stroke mRS score:  
No disability – mRS 1† 1.75 0.83 – 3.68 
Slight disability – mRS 2† 3.63 1.61 – 8.19 
 Moderate disability – mRS 3† 3.22 1.59 – 6.52 
Moderately severe – mRS 4† 3.34 1.06 – 10.52 
Admission NIHSS score:  
Moderate (NIHSS 5 – 15)‡ 1.36 0.29 – 6.46 
Moderate–Severe (NIHSS 16 – 20)‡ 2.95 0.62 – 13.97 
Severe (NIHSS 21 – 42)‡ 5.92 1.28 – 27.49 
Site of occlusion:  
Internal carotid artery 2.06 1.00 – 4.22 
Posterior circulation 1.83 0.81 – 4.10 
Procedural Characteristics 
Number of device passes:  
2 passes** 1.06 0.57 – 2.00 
≥ 3 passes** 1.73 0.99 – 3.05 
Endovascular measures: 
Clot obtained after each pass 0.41 0.25 – 0.68 
Successful recanalization (≥ 2B)ǁ 0.20 0.08 – 0.50 
Time to recanalization (hours) 1.21 0.93 – 1.58 
Rescue angioplasty†† 1.20 0.61 – 2.39 
Intra-arterial therapy‡‡ 0.61 0.22 – 1.67 
Periprocedural adverse events:  
Any procedural complication 2.73 1.65 – 4.53 
Distal emboli during procedure 1.08 0.48 – 2.47 
Any intracranial hemorrhage 2.67 1.55 – 4.61 
Symptomatic ICH§ 23.57 7.96 – 69.81 
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-Crude odds ratios (ORs) were estimated from univariate logistic regression: Adjusted odds ratios (ORs) were 
estimated from multivariable logistic regression: ORs estimate the relative odds of death within 90 days among 
patients with or without the factor shown, except where other categories are indicated. 
-CI, confidence interval; TIA, transient ischemic attack; mRS, modified Rankin Scale; NIHSS, National Institute 
of Health Stroke Scale; ICA, internal carotid artery. 
†Pre-stroke mRS score: vs. mRS score 0, defined as no symptoms and total functional independence. 
‡Admission NIHSS score: vs. minor NIHSS score (0–4), defined as subclinical to minimal neurologic deficits. 
*Age: vs. < 60 years. **Number of device passes: vs. 1 pass of thrombectomy stent–retriever device. 
ǁSuccessful recanalization was defined as achieving a TICI score of 2B or 3 (≥50% or complete restoration of flow at the site of arterial 
occlusion). ††Techniques included balloon dilation and stent implantation.  
‡‡Intra-arterial thrombolytics (t-PA) or anti-platelet therapy (eptifibatide). 
§Symptomatic intracerebral hemorrhage (ICH) was defined as subarachnoid or intraparenchymal hemorrhage at 
12–36 hours associated with ≥ 4 point worsening of NIHSS or ≥ 1 point deterioration in level of consciousness.  
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Table 4.  Multivariable Analysis of Factors Associated with 90–Day Mortality 
  Model 1
1 Model 22 
Variable OR 95% CI OR 95% CI 
Prior stroke or TIA 0.28 0.09 – 0.68 0.27 0.07 – 1.05 
Pre-stroke mRS 1† 2.06 0.91 – 4.69 3.05 1.21 – 7.7 
Pre-stroke mRS 2† 3.75 1.50 – 9.39 4.43 1.55 – 12.65 
Pre-stroke mRS 3† 3.39 1.55 – 7.42 3.84 1.56 – 9.45 
Pre-stroke mRS 4† 6.25 1.72 – 22.66 5.06 1.09 – 23.51 
Admission NIHSS 5–15‡ 2.83 0.33 – 24.36 8.97 0.21 – 388.48 
Admission NIHSS 16–20‡ 6.12 0.72 – 52.29 20.61 0.47 – 907.26 
Admission NIHSS 21–42‡ 12.36 1.48 – 103.27 56.36 1.28 – 999.99 
ICA occlusion 2.77 1.18 – 6.55 3.28 1.22 – 8.86 
Posterior occlusion 2.69 1.06 – 6.83 1.95 0.65 – 5.83 
Clot obtained after each pass — — 0.49 0.24 – 1.00 
Successful recanalization (≥ 2B)ǁ — — 0.21 0.06 – 0.80 
Symptomatic ICH§ — — 17.89 5.22 – 61.29 
 
1Model 1 was developed using backward selection of only baseline characteristics, with a significance level of p 
≤ 0.05 for variable retention. Akaike information criterion (AIC) = 323.3  2Model 2 was pre–specified to include 
baseline prognostic factors from Model 1 and clinically relevant procedural characteristics. AIC = 263.4 
-Adjusted odds ratios (ORs) were estimated from multivariable logistic regression: ORs estimate the relative 
odds of death within 90 days among patients with or without the factor shown, except where other categories are 
indicated.  
-CI, confidence interval. TIA, transient ischemic attack; mRS, modified Rankin Scale; NIHSS, National Institute 
of Health Stroke Scale; ICA, internal carotid artery; Successful recanalization was defined as achieving a TICI 
score of 2B or 3 (≥50% or complete restoration of flow at the site of arterial occlusion). 
†Pre-stroke mRS score: vs. mRS score 0, defined as no symptoms and total functional independence. 
‡Admission NIHSS score: vs. minor NIHSS score (0–4), defined as subclinical to minimal neurologic deficits. 
§Symptomatic intracerebral hemorrhage (ICH) was defined as subarachnoid or intraparenchymal hemorrhage at 
12–36 hours associated with ≥ 4 point worsening of NIHSS or ≥ 1 point deterioration in level of consciousness.  
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CHAPTER IV: DISCUSSION 
 
 
 This study analyzed a variety of prognostic factors associated with 90-day mortality after 
emergent mechanical thrombectomy among patients with an acute LVO stroke. The overall 
mortality rate during the 90 day post-procedural period for this study population was 28.5%, 
which is comparable to findings in prior registry studies with similar study design and inclusion 
criteria.8, 11, 17, 30-32 Major findings from multivariable modeling showed that the baseline 
characteristics of pre-stroke mRS score, admission NIHSS, history of stroke or TIA, ICA 
occlusion, and posterior occlusion were independent indicators of mortality, baseline functional 
and stroke severity scores remained important when combined with procedural parameters, and 
clot extraction after each pass, successful recanalization, and sICH post-procedure were also 
independently associated with an increased or decreased risk of dying after endovascular 
intervention. 
Admission NIHSS 
 High admission NIHSS (21 – 42), specifically in the score range classified as severe 
stroke, was independently associated with increased mortality by 3 month follow-up. This 
finding was consistent with several studies. Both Linfante and Gory et al. reported high NIHSS 
on admission to be predictive of mortality at 3 months despite successful recanalization.14, 17 Shi 
et al. also reported baseline NIHSS score to be an independent predictor of functional depen-
dence (mRS 3-6) despite successful revascularization.33 These consistent findings demonstrate 
the difficulty of reversing a severe neurological deficit at stroke onset even with immediate and 
successful endovascular reperfusion. However, a high NIHSS at presentation should not be used 
to exclude patients from thrombectomy eligibility, because patients with severe NIHSS scores 
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have even worse outcomes with IV t-PA and medical management alone than with endovascular 
therapy.8, 10, 33  
Pre-stroke mRS 
 Similar to stroke severity, pre-stroke mRS was another baseline characteristic that was 
independently associated with 90-day mortality in this study. The estimated effect of baseline 
functional status on risk of death also increased as the mRS disability score increased. This is a 
novel finding, as a graded association between pre-stroke functional dependence and risk of post-
thrombectomy mortality has not been reported previously. These results show the importance of 
considering not just stroke severity and neurologic deficits through NIHSS, but also assessing 
baseline global functioning when determining which stroke patients may benefit from stent-
retriever thrombectomy. 
History of Stroke or TIA 
 Surprisingly, a history of previous stroke or TIA was inversely associated with mortality 
in this study and may have a protective effect on post-thrombectomy outcomes. Yoon et al. 
found the opposite association, in which mortality occurred more frequently in patients with 
previous stroke or TIA than those with no cerebrovascular history.31 Prior stroke or TIA was 
found as a predictor of both short-term and long-term mortality in AIS patients compared to 
healthy controls in other observational studies.34, 35 In contrast, both Awad and Sharobeam et al. 
reported that having a prior stroke or TIA was not a significant factor in poor outcomes after 
thrombectomy for AIS. 36-37 Bouslama et al. observed that repeated mechanical thrombectomy in 
patients with a recurrent history of LVO stroke was both safe and feasible.38  
A possible explanation for our unique findings on the protective association of recurrent 
stroke or TIA may be that having survived a prior AIS is a proxy for good collateral circulation. 
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Adequate collateral perfusion has been correlated with LVO strokes that are asymptomatic or 
produce only minimal neurologic deficits.39 Future research is needed to clarify the utility and 
prognosis of thrombectomy for patients with a history of stroke and to better manage vascular 
risk factors for preventing recurrent stroke.  
ICA and Posterior Circulation Occlusions 
 We found that vessel occlusions located in the ICA and posterior circulation were 
associated with increased death within 90 days of endovascular treatment. Site of occlusion in 
the ICA retained significance in multivariable analyses of both baseline and procedural 
characteristics, while LVO located in the posterior arteries no longer influenced mortality when 
procedural parameters were accounted for in the model. This was likely due to the study being 
underpowered to detect significant differences, with few cases of posterior circulation strokes 
overall. Specifically, basilar artery occlusions account for 5% of LVOs, yet are associated with 
68% to 78% severe disability and mortality in studied patients treated with mechanical 
thrombectomy.40 The frequency of this dismal prognosis has led to basilar artery occlusions often 
being referred to as the “orphan” of LVOs. 40  
Similar to posterior occlusions, acute ICA occlusions have been associated with poor 
outcomes.14, 17 This correlation may be due to high initial infarct volumes in proximally occluded 
vessels and technical challenges in recanalizing ICA occlusions.14 Patients with posterior and 
ICA strokes were initially excluded from the landmark endovascular RCTs. 6-11 However, 
angioplasty and stenting of these types of occlusions have resulted in favorable clinical 
outcomes,14 leading to thrombectomy now being recommended for certain acute presentations of 
vertebrobasilar and ICA strokes. These collective findings substantiate the need for the inclusion 
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of ICA and posterior occlusion strokes in future trials, to elucidate the relationship between 
anatomical site and prognosis as well as improve upon thrombectomy outcomes.  
Successful Recanalization and Clot Extraction 
 Several prior studies using older generation stent retriever devices have found 
recanalization status (as classified by the TICI scoring system) to be a strong indicator of 
prognosis and clinical outcomes.11, 14, 17, 31 The present study using the newest generation devices 
is consistent with these results. Successful recanalization to a mTICI score of 2B (≥ 50% 
reperfusion) or greater continues to be inversely associated with mortality after thrombectomy. 
Recent studies have shown that achieving complete restoration of blood flow to a mTICI score of 
3 resulted in reduced infarct growth and greater post-thrombectomy functional independence 
than revascularization only to 2B.41 Future research on AIS patients undergoing endovascular 
therapy should explore whether successful recanalization should be redefined as achieving a 
mTICI 3 score. A unique surgical parameter not evaluated in other studies was whether part or 
all of the clot was obtained from each pass of the stent retriever. We found that a clot yielded 
after each pass of the device was marginally and inversely associated with death at 90 days. This 
slight protective effect considers the benefit of optimizing surgical techniques and warrants 
further exploration of more efficient technical strategies. 
Symptomatic Intracranial Hemorrhage 
 Finally, the periprocedural complication of symptomatic ICH 12 to 36 hours after 
mechanical thrombectomy demonstrated the strongest association with 90-day mortality after 
thrombectomy in multivariable analysis. This was in direct contrast to Gory’s observations that 
procedure-related adverse events and occurrence of ICH were not correlated with death.17 
However, our results were consistent with other single and multi-center study findings 
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supporting that parenchymal ICH was associated with higher rates of mortality and poor 
outcome.11, 31 ICH can result from reperfusion injury after prolonged ischemia or can occur due 
to vessel wall perforation as a technical complication of the endovascular procedure.36 Thus, 
sICH is a strong prognosticator of post-thrombectomy death that is potentially modifiable by 
either shortening the amount of time it takes to receive endovascular treatment or by improving 
intraprocedural techniques to prevent fatal operator-induced brain bleeds.  
Study Strengths and Limitations 
Findings of this study reveal several important associations and potential prognosticators 
for 90-day mortality after thrombectomy for AIS. However, there are some limitations that need 
to be considered in this single center observational study. First, this was an unsponsored non-
randomized registry study limited by its retrospective design. The single-center design and 
mostly Caucasian study population may limit generalizability of the results. Given the sparsity of 
available thrombectomy intervention overall for AIS patients with LVO, this study had a 
considerable and greater sample size relative to most endovascular stroke trials.8-12 Despite the 
high volume of study patients treated at this comprehensive stroke center, we may still have been 
underpowered to detect certain significant differences.  
This study analyzed many unique factors for influence on mortality after endovascular 
intervention, however we did not evaluate baseline blood glucose. Blood glucose levels at 
admission have been associated with mortality following stent-retriever thrombectomy and thus 
may have been a potential confounder that was unaccounted for.11, 30 Due to incomplete 
availability of radiographic images from patients transferred from outside facilities, the Alberta 
Stroke Program Early CT Score (ASPECTS) score at presentation was also not consistently 
assessed. Although unfavorable ASPECTS scores have been associated with poor functional 
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outcomes in prior studies, the score is limited to the anterior circulation. 27, 28 There is also 
disagreement over the methodological constraints and utility of ASPECTS in predicting 90-day 
mortality.29 Future large prospective multi-center studies evaluating novel and aforementioned 
factors are needed to validate the present findings, predict prognosis at varying time points after 
undergoing thrombectomy, and improve outcomes in emergent endovascular intervention for 
patients with AIS.  
Conclusion 
Although recent advances in endovascular therapy have improved patient prognosis and 
continue to expand the utility of mechanical thrombectomy for patients with acute stroke, a 
considerable proportion of patients die during a relatively short follow-up. Mortality after 
successful thrombectomy is multifactorial, as evidenced by varied and conflicting findings in 
previous reports. Multivariable analyses of the present study findings revealed that pre-stroke 
mRS, admission NIHSS, history of stroke or TIA, ICA or posterior occlusion, high-yield clot 
extraction per pass, successful recanalization, and post-procedure sICH are independent factors 
associated with 90-day mortality after thrombectomy for AIS. These findings may differentiate 
patients who are more suited for endovascular intervention, inform prognosis evaluation, and 
help guide shared decision-making on mechanical thrombectomy for LVO stroke. Further 
research is needed to reach a consensus on risk-adjustable factors and modifiable procedural 
characteristics to better select candidates for thrombectomy and improve upon endovascular 
treatment of acute ischemic stroke. 
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Glossary of Abbreviations 
 
AIC Akaike’s information criterion 
AIS acute ischemic stroke 
ASPECTS Alberta Stroke Program Early CT Score  
CT computed tomography 
ICA intracranial internal carotid artery 
ICH intracranial hemorrhage 
IQR interquartile ranges 
IA intraarterial 
IV intravenous 
LVO large vessel occlusions 
MCA middle cerebral arteries 
MRI magnetic resonance imaging 
mRS modified Rankin Scale 
mTICI modified thrombolysis in cerebral infarction 
NIHSS National Institutes of Health Stroke Scale 
PCA posterior cerebral artery 
RCT randomized controlled trial 
sICH symptomatic intracranial hemorrhage 
SD standard deviation 
TIA transient ischemic attack 
t-PA tissue-plasminogen activator 
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